Last mentioned: Jul 15, 2026
Across the most recent 10 stories covering TD Cowen — 10% positive, 10% negative, 80% neutral sentiment, averaging 5.2/10 impact.
This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Wells Fargo Cuts Target to $70
Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
Bank of America Lowers Target
Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
TD Cowen Sets Street-High $73 Target
TD Cowen raised target from $63 to $73, the highest among all analysts, maintaining a Buy rating.
Piper Sandler Stays Overweight
Piper Sandler reaffirms an Overweight rating on Freshpet shares.
Weiss Ratings Downgrades
Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
Morgan Stanley Revises Target to $51
Morgan Stanley raised target from $38 to $51 but kept Equal Weight rating, signaling a cautious stance.
Analyst Surge: Four Firms Raise Targets
Oppenheimer, Goldman Sachs, KeyCorp, and Barclays all lifted price targets to the $55–$60 range, reiterating Buy/Outperform ratings.
JPMorgan Upgrades, Others Reaffirm
JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
Jefferies Cuts Target
Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
TD Cowen Turns Bullish
TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
Market Outperformance
Financial media highlights Grail as the week's top performer in the diagnostics sector.
Volume Surge
Stock sees highest trading volume in six months as institutional buyers return.
Oppenheimer Upgrades Freshpet
Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.
TD Cowen Upgrade
Analysts upgrade Grail to 'Buy,' citing an oversold condition and strong core fundamentals.
Market Low
GRAL stock hits a 52-week low amid heavy selling pressure.
CEO Transition
Bob Ragusa steps down as CEO following reports of a trial setback.
Zacks Downgrades to Hold
Zacks Research downgraded Forgent Power Solutions to a Hold rating amid valuation concerns.
Analyst Target Cuts
TD Cowen and Canaccord Genuity slash price targets citing competitive risks and valuation.
Market Volatility
VEEV stock surges 11% on long-term outlook before retreating on disclosure concerns.
Q4 Earnings Report
Veeva reports advancing income and sets a $6B revenue target for 2030.
Morgan Stanley lowered its BlackRock (BLK) price target to $1,383 while maintaining Overweight, implying a 34% gain. The consensus remains Moderate Buy with an average target of $1,270.72. Diverging analyst revisions signal both caution and opportunity for the asset management giant.
Source: Zolmax · Markets Daily
Pentair’s revised Q2 2026 guidance stunned investors, with EPS of $1.12 against a $1.48 estimate and revenue of $930M, well below the $1.1B consensus. The stock slid to $75.74 on heavy volume, its 200-day MA, and the new full-year EPS range of $4.60-4.80 implies a 10-14% miss, triggering a fresh round of analyst target cuts.
Source: MarketBeat · MarketBeat
Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Source: Watch List News · Ticker Report
Forgent Power Solutions draws a 'Moderate Buy' consensus from 13 analysts with an average price target of $55.36, implying 18% upside. Ten firms rate it a Buy or Outperform, driven by surging demand for data center electrical equipment and grid modernization.
Source: Bbns · The Lincolnian Online
Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm.
Source: themarketsdaily.com · zolmax.com
United Airlines CEO Scott Kirby has signaled that ticket prices could rise by as much as 20% if jet fuel costs remain at current elevated levels. The warning highlights the growing pressure on airline margins as energy volatility threatens to disrupt travel demand and sector profitability.
Grail (GRAL) shares outperformed the broader market this week, staging a dramatic recovery following a sharp selloff earlier in the month. Investor sentiment shifted after a key analyst upgrade and a reassessment of the long-term impact of a recent clinical trial setback.
Veeva Systems (VEEV) is navigating a complex post-earnings landscape as major analysts, including TD Cowen and Canaccord Genuity, significantly lower their price targets. Despite a bullish long-term revenue outlook, recent management disclosures regarding competitive losses have triggered a wave of valuation adjustments across Wall Street.
RBC Capital has initiated coverage of AbbVie with an 'Outperform' rating, signaling confidence in the company's ability to navigate the post-Humira landscape. Analysts believe the market has over-discounted the growth potential of AbbVie's next-generation immunology drugs and its durable aesthetics portfolio.
TD Cowen has downgraded digital intelligence leader Cellebrite (CLBT), citing a broader contraction in the forensics market. Despite the company's robust annual recurring revenue growth, analysts warn that tightening government budgets and market saturation could limit near-term upside.
Source: finance.yahoo.com · insidermonkey.com
This page surfaces every story mentioning TD Cowen across our finance coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running finance beat. Cross-entity comparisons live on our compare view.
Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where TD Cowen was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |